Dendritic cells in remodeling of lymph nodes during immune responses

Immunological Reviews

Volumn 271, Issue 1, 2016, Pages 221-229

  Acton, Sophie E ^a,b   Reis e Sousa, Caetano ^a  

^a THE FRANCIS CRICK INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dendritic cells; Fibroblastic reticular cells; High endothelial venule; Inflammation; Lymph node; Stroma

Indexed keywords

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL EXPANSION; DENDRITIC CELL; FIBROBLAST; IMMUNE RESPONSE; IMMUNOREGULATION; INTRACELLULAR SIGNALING; LYMPH NODE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STROMA CELL; ANIMAL; HOMEOSTASIS; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; DENDRITIC CELLS; FIBROBLASTS; HOMEOSTASIS; LYMPH NODES; STROMAL CELLS;

EID: 84963610867     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12414     Document Type: Article

References (75)

1. Yang C-Y, et al. Trapping of naive lymphocytes triggers rapid growth and remodeling of the fibroblast network in reactive murine lymph nodes. Proc Natl Acad Sci USA 2013;111:E109-E118.
2. Lämmermann T, Sixt M. The microanatomy of T-cell responses. Immunol Rev 2008;221:26-43.
3. Link A, et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol 2007;8:1255-1265.
4. von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3:867-878.
5. Webster B, Ekland EH, Agle LM, Chyou S, Ruggieri R, Lu TT. Regulation of lymph node vascular growth by dendritic cells. J Exp Med 2006;203:1903-1913.
6. Acton SE, et al. Dendritic cells control fibroblastic reticular network tension and lymph node expansion. Nature 2014;514:498-502.
7. Worbs T, Mempel TR, Bölter J, von Andrian UH, Förster R. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J Exp Med 2007;204:489-495.
8. Woolf E, et al. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces. Nat Immunol 2007;8:1076-1085.
9. Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 2003;198:937-945.
10. Girard J-P, Moussion C, Förster R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 2012;12:762-773.
11. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-252.
12. Randolph GJ, Ochando J, Partida-Sánchez S. Migration of dendritic cell subsets and their precursors. Annu Rev Immunol 2008;26:293-316.
13. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2006;7:19-30.
14. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 2005;5:617-628.
15. Katakai T. A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. Int Immunol 2004;16:1133-1142.
16. Heuzé ML, et al. Migration of dendritic cells: physical principles, molecular mechanisms, and functional implications. Immunol Rev 2013;256:240-254.
17. Förster R, Schubel A, Breitfeld D, Kremmer E. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23-33.
18. Weber M, et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science 2013;339:328-332.
19. Acton SE, et al. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity 2012;37:276-289.
20. Mourão-Sá D, et al. CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses. Eur J Immunol 2011;41:3040-3053.
21. Lowe KL, et al. The expression of mouse CLEC-2 on leucocyte subsets varies according to their anatomical location and inflammatory state. Eur J Immunol 2015;45:2484-2493.
22. Malhotra D, et al. Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol 2012;13:499-510.
23. Tal O, et al. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J Exp Med 2011;208:2141-2153.
24. Ulvmar MH, et al. The atypical chemokine receptor CCRL1 shapes functional CCL21 gradients in lymph nodes. Nat Immunol 2014;15:623-630.
25. Itano AA, et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 2003;19:47-57.
26. Sixt M, et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 2005;22:19-29.
27. Gerner MY, Torabi-Parizi P, Germain RN. Strategically localized dendritic cells promote rapid T cell responses to lymph-borne particulate antigens. Immunity 2015;42:172-185.
28. Gretz JE, Anderson AO, Shaw S. Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex. Immunol Rev 2005;156:11-24.
29. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med 2000;192:1425-1440.
30. Rantakari P, et al. The endothelial protein PLVAP in lymphatics controls the entry of lymphocytes and antigens into lymph nodes. Nat Immunol 2015;16:386-396.
31. Junt T, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature 2007;450:110-114.
32. Iannacone M, et al. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature 2010;465:1079-1083.
33. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lämmermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012;150:1235-1248.
34. Phan TG, Grigorova I, Okada T, Cyster JG. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 2007;8:992-1000.
35. Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity 2007;27:160-171.
36. Gaya M, et al. Host response. Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection. Science 2015;347:667-672.
37. Moussion C, Girard J-P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011;479:542-546.
38. Chyou S, et al. Fibroblast-type reticular stromal cells regulate the lymph node vasculature. J Immunol 2008;181:3887-3896.
39. + cells and then by T and B cells. J Immunol 2011;187:5558-5567.
40. Kumar V, et al. A dendritic-cell-stromal axis maintains immune responses in lymph nodes. Immunity 2015;42:719-730.
41. van Blijswijk J, et al. Altered lymph node composition in diphtheria toxin receptor-based mouse models to ablate dendritic cells. J Immunol 2015;194:307-315.
42. Newman DK. CLEC-2: the inside story. Blood 2015;125:3972-3974.
43. Herzog BH, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 2013;502:105-109.
44. Cyster JG. Chemokines, Sphingosime-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005;23:127-159.
45. Astarita JL, et al. The CLEC-2-podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture. Nat Immunol 2014;16:75-84.
46. Krishnan H, et al. Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility. J Biol Chem 2013;288:12215-12221.
47. Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M. Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci 2006;119:4541-4553.
48. Olson MF, Sahai E. The actin cytoskeleton in cancer cell motility. Clin Exp Metastasis 2009;26:273-287.
49. Fernández-Muñoz B, et al. The transmembrane domain of podoplanin is required for its association with lipid rafts and the induction of epithelial-mesenchymal transition. Int J Biochem Cell Biol 2011;43:886-896.
50. Asai J, et al. Platelets regulate the migration of keratinocytes via podoplanin/CLEC-2 signaling during cutaneous wound healing in mice. Am J Pathol 2015;186:101-108.
51. Pollitt AY, et al. Syk and Src family kinases regulate C-type lectin receptor 2 (CLEC-2)-mediated clustering of podoplanin and platelet adhesion to lymphatic endothelial cells. J Biol Chem 2014;289:35695-35710.
52. Fei M, et al. The production of soluble C-type lectin-like receptor 2 is a regulated process. Glycoconj J 2012;29:315-321.
53. Pedersen SF, Nilius B. Transient receptor potential channels in mechanosensing and cell volume regulation. Meth Enzymol 2007;428:183-207.
54. Dupont S, et al. Role of YAP/TAZ in mechanotransduction. Nature 2011;474:179-183.
55. Ehmer U, Sage J. Control of proliferation and cancer growth by the Hippo signaling pathway. Mol Cancer Res 2015. pii: molcanres.0305.2015. [Epub ahead of print].
56. Gil-Ortega M, et al. Native adipose stromal cells (ASCs) egress from adipose tissue in vivo: evidence during lymph node activation. Stem Cells 2013;31:1309-1320.
57. Jarjour M, et al. Fate mapping reveals origin and dynamics of lymph node follicular dendritic cells. J Exp Med 2014;211:1109-1122.
58. Krautler NJ, et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 2012;150:194-206.
59. Chai Q, et al. Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity 2013;38:1013-1024.
60. Benezech C, et al. Ontogeny of stromal organizer cells during lymph node development. J Immunol 2010;184:4521-4530.
61. Bénézech C, et al. Lymphotoxin-β receptor signaling through NF-κB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells. Immunity 2012;37:721-734.
62. Peduto L, et al. Inflammation recapitulates the ontogeny of lymphoid stromal cells. J Immunol 2009;182:5789-5799.
63. Shields JD, Kourtis IC, Tomei AA, Roberts JM. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 2010;328:749-752.
64. Jung Y, et al. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun 2013;4:1795.
65. Calvo F, et al. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat Cell Biol 2013;15:637-646.
66. De Wever O, Demetter P, Mareel M, Bracke M. Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008;123:2229-2238.
67. Lax S, et al. CD248/Endosialin is dynamically expressed on a subset of stromal cells during lymphoid tissue development, splenic remodeling and repair. FEBS Lett 2007;581:3550-3556.
68. MacFadyen JR, et al. Endosialin (TEM1, CD248) is a marker of stromal fibroblasts and is not selectively expressed on tumour endothelium. FEBS Lett 2005;579:2569-2575.
69. Juarez M, Filer A, Buckley CD. Fibroblasts as therapeutic targets in rheumatoid arthritis and cancer. Swiss Med Wkly 2012;142:w13529.
70. Lax S, et al. The pericyte and stromal cell marker CD248 (endosialin) is required for efficient lymph node expansion. Eur J Immunol 2010;40:1884-1889.
71. Ohradanova A, et al. Hypoxia upregulates expression of human endosialin gene via hypoxia-inducible factor 2. Br J Cancer 2008;99:1348-1356.
72. Fonseca DMD, et al. Microbiota-dependent sequelae of acute infection compromise tissue-specific immunity. Cell 2015;163:354-366.
73. Estes JD. Pathobiology of HIV/SIV-associated changes in secondary lymphoid tissues. Immunol Rev 2013;254:65-77.
74. Zeng M, et al. Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. J Clin Invest 2011;121:998-1008.
75. Anthony DD, et al. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J Immunol 2004;172:4907-4916.